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Abstract
Cholecystokinin 33 (CCK) was infused 
intravenously to eight healthy obese 
women and 10 healthy lean women o f the 
same age, in doses that elicited plasma 
cholecystokinin concentrations in the 
physiological range. The effect o f these 
infusions after a standardised banana 
‘shake5 (preload) on food intake and 
satiety signals was compared with the 
effect of saline infusions in the same 
subjects. For the whole group food intake 
(mean (SEM)) (282 (29 g)) was signifi­
cantly less during CCK than during saline 
(346 (31) g, p<0*05). Hunger feelings 
tended to be less during CCK infusions. 
Examination of the separate subgroups 
showed no differences between lean and 
obese subjects in the satiety effects of 
CCK. In conclusion, under the conditions 
o f  this study5 CCK significantly decreases 
food intake in humans, and this effect is 
sim ilar for lean and obese subjects.
(Gut 1995; 36; 176-179}
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Many studies have shown that cholecystokinin 
(CCK) reduces food intake in several species 
including humans. l~14 In these studies, how­
ever, CCK plasma concentrations were not 
measured and the reported feeding depression 
may well have been caused by supraphysio- 
logical doses of CCK. Wolkowitz on the other 
hand reported that CCK receptor blockade 
increased hunger in humans showing that 
CCK may have a physiological satiety effect 
also in humans.15 It has recently been shown 
that an infusion of CCK 33 leading to high 
physiological plasma concentrations does not 
have an important effect on food intake and 
postprandial satiation in humans in a study 
where no preload was given.16 A gastric load, 
however,, potentiates the inhibition of food 
intake produced by cholecystokinin and 
reduces the threshold dose of a CCK analogue 
required to inhibit food intake in monkeys and 
rats.1217 In the human studies of Pi-Suyner 
and Kissileff where a CCK 8 infusion dimin­
ished food intake in lean and obese humans, 
an appetiser* consisting of crackers and jelly 
(216 kcal) was given 12 minutes before the 
start of the liquid meal.3 4 Muurahainen ei al 
reported that a 500 g but not 100 g soup pre­
load combined with CCK 8 225 ng/ml/min 
significantly decreased food intake in non- 
obese humans compared with the same pre­
load with a saline infusion.18 We therefore 
studied the effects of intravenous infusion of
CCK 33, in a dose that leads to high physio­
logical plasma concentrations, on food intake, 
15 minutes after a preload, and satiety signals 
in lean and obese volunteers. Apart from the 
preload this study design is comparable with 
our previous investigation,16 We infused CCK 
33 into the volunteers, as we have shown that 
CCK 33 like immunoreactivity represents one 
of the important circulating molecular forms in 
humans, whereas CCK 8 was almost absent.19 
Given that the octapeptide of CCK is almost 
absent in human plasma it is probable that 
the human studies on CCK 8 and satiety 
examined a pharmacological effect rather 
than the physiological effect of CCK that we 
investigated using CCK 33.
Methods
Eight healthy obese women (age 41 (3) years, 
body mass index of 39 (2) kg/m2) and 10 age 
and sex matched healthy lean women (age 41 
(2) years with a body mass index of 22 (3) 
kg/m2) were studied. Informed consent was 
obtained from all subjects. The investigations 
were approved by the local human ethics 
committee.
After an overnight fast the volunteers came 
to the laboratory at 0800. Saline or highly 
purified CCK 33 (1 IDU/kg ideal weight 
height, Karolinska Institute, Stockholm, 
Sweden) was infused through an intravenous 
catheter for 165 minutes, in random order and 
double blinded. The subjects actual weight 
was used as the ideal weight in the lean 
subjects and for obese subjects their height in 
cm was subtracted by 100 because it was 
known from previous experiments that this 
resulted in comparable plasma concentra­
tions.16 The infusion was started at 0900. The 
two studies were separated from each other by 
at least one week. The subjects were investi­
gated on days irrespective of their time in the 
menstrual cycle. Sixty minutes after the start of 
the saline or CCK infusion, a banana ‘shake* 
consisting of 100 g of banana slices, supple­
mented with 300 ml of water and mixed 
(132 kcal), was served and consumed within 
three minutes. Fifteen minutes later, at t=75 
minutes a solid meal of slices of bananas in 
abundancy, containing 1 g/100 g of protein,
0 g/100 g of fat, and 32 g/100 g of carbohydrate 
was served and the meal was weighed before 
and afterwards to determine the exact amount 
of food consumed.
Banana slices were chosen because most 
people like them and they have only minimal 
CCK stimulating potency as was shown in our 
previous study without a preload.16
Otherwise, if the preload or meal had
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Figure 1: (A) Desire to eat3 (B) hunger, (C) fullness, and (D) prospective feeding intentio?is during saline or 
cholecystokinin infusions from t= 0  until t= 1 6 5  minutes in 18 healthy women. After 60 minutes a banana 1shake1 
(preload—P) was consumed and 15 minutes later a meal
CO
E<D
stimulated endogenous CCK release this 
might have led to supraphysiological plasma 
CCK concentrations in combination with the 
CCK infusion. Subjective criteria, like desire
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Figure 2: (A) Desire to eat caloric items in 18 healthy women during saline or C C K  
infusion. After 60 minutes a banana <shakey (preload=P) was consumed and 15 minutes 
later a meal. After the meal C C K  induced a significant satiety effect when the incremental 
area under the curve was analysed (p<0-05). (B) Desire to eat fatty items in 18 healthy 
women during saline or C C K  infusion. After 60 minutes a banana eshakei (preload—P) 
was consumed and 15 minutes later a meal. After the meal C C K  induced a significant 
satiety effect for fatty items when the increm ental area under the curve was analysed
(pCO-OS).
to eat, hunger feeling., fullness, and prospective 
feeding intentions were scored on 100 mm 
visual analogue scales basally and at 15 minute 
intervals after the meal until 60 minutes after 
the end of the infusion period.20 21 Questions 
asked were: how strong is your desire to eat 
(very weak -  very strong); how, hungry do you 
feel (not hungry at all -  as hungry as I have ever 
felt); how full do you feel (not at all full -  very 
full); how much food do you think you could 
eat (nothing -  very much). Hunger feelings 
were also measured with food selection lists as 
described by Hill22 and modified to Dutch 
feeding customs. Fifteen minutes before the 
infusion^ 15 minutes before the banana 'shake5 
(at t= 45)3 15 minutes after the meal (at t—90), 
and at t = 120, t=  165 (end of the infusion)* and 
t=225 (end of the experiment), lists and 
photographs showing six protein rich, six fat 
rich, six carbohydrate rich (each (200) kcal), 
and six low energy items were presented. From 
each of these 24 items the subjects were asked 
if they wanted to eat immediately the amount 
shown, double the amount, half the amount 
or nothing at all independent of the other 
items. At each time interval the total amount 
of caloric items was calculated (half the 
amount^ V2 caloric item, double the 
amount=2 caloric items). The subjects also 
indicated on visual analogue scales if they 
appreciated the meal and if they experienced 
nausea. Plasma CCK concentrations were 
measured by a sensitive and specific radio­
immunoassay using antibody T 204‘ This anti­
body binds to all carboxy terminal CCK  
peptides containing the sulphated tyrosyl 
region and recognises biologically active CCK  
forms equally. The detection limit of the 
assay was 0-5 pmol/1 plasma. All samples were 
measured in one run. The intra-assay variation 
ranged from 4*6 to 11*5%.23 24
Results are given as mean (SEM). Statistical 
analysis of hunger feelings was done by calcu­
lating the integrated area under the curve
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Figure 3: Plasma C C K  concentrations during saline (open 
symbols) or C C K  infusion (closed symbols) in (A) lean or 
(B) obese women. After 60 minutes a banana (shakeJ 
(preload~P) was consumed and 15 minutes later a meal 
Basal concentrations were comparable in lean and obese 
■women as were the plasma concentrations during C C K  
infusion.
(AUC) before and after the meal followed by 
Wilcoxon matched pairs, signed rank test. 
Food intake and plasma CCK concentrations 
were compared using Wilcoxon’s matched 
pairs signed rank test. Differences between 
lean and obese subjects were analysed using 
the Mann-Whitney U test.
Results
During CCK infusion food intake (282 (29) g) 
was significantly less for the 18 women than 
during saline infusion (346 (31) g, p<0*05). 
Subjective criteria, like desire to eat, hunger 
feelings, and prospective feeding intentions 
tended to be less during CCK infusions 
(Fig 1), but the differences did not reach statis­
tical significance (p<0*06 for the AUC before 
and p=0*09 for the AUC after the meal for 
desire to eat and p=0*08 for the AUC after the 
meal for hunger feelings),
There was also a significant satiating effect 
of CCK after the meal according to the food 
selection lists p<0-05 (Fig 2). Analysing 
the protein, fatty, and carbohydrate items 
separately, this satiating effect of CCK was
- specific for the fatty items, but not for the 
protein and carbohydrate rich items.
During CCK infusion in the lean women 
food intake (295 (45)) was also less than 
during saline (358 (43) g) but this difference 
just failed to reach significance (p = 0’06). Also 
in the obese women CCK infusion induced a 
feeding depression from 331 (49) g during 
saline to 265 (36) g during CCK infusion 
(NS). There were also no differences found 
between lean and obese women with regard to 
subjective hunger feelings apart from a signifi­
cantly lower postprandial desire for fatty items
in lean women during CCK (p<0*05) whereas 
there was no difference in obese women 
between saline and CCK.
Basal plasma CCK concentrations were not 
significantly different before the saline (2*7 
(0'2) pM) and CCK infusion (2*6 (0*1) pM) 
and not significantly different in lean (2-9 
(0*3) pM) and obese subjects (2*5 (02) pM).
Infusion of saline failed to significantly affect 
basal CCK concentrations in both lean and 
obese volunteers (Fig 3). Infusion of CCK 
resulted in significant increases of plasma 
CCK concentrations to values fluctuating 
around 12 pM in both lean and obese subjects 
(Fig 3). To stop the CCK infusion resulted in 
rapidly declining plasma CCK concentrations, 
which reached basal values within 30 minutes.
One of the lean subjects experienced a 
headache during both the saline and CCK 
experiment and another lean subject developed 
diarrhoea during the CCK experiment. There 
were no other adverse effects. In the lean 
subjects the duration of the meal was signifi­
cantly shorter with CCK (5*3 (0*88) min) than 
with saline (7*8 (1*43) min, p<0-05) whereas 
in obese subjects the duration of the meal with 
CCK (7*25 (1) min) and saline (7-5 (0*71) 
min) was comparable.
The appreciation of the meal was com­
parable between the saline and CCK experi­
ment (60 (5) v  64 (6) mm) and there was no 
nausea in lean and obese subjects.
Discussion
This study shows for the first time that 
exogenously given CCK 33, resulting in 
plasma CCK concentrations seen after a mixed 
meal,23 significantly diminishes the size of 
a carbohydrate meal and increases postmeal 
satiety in humans. There were no clear differ­
ences in these satiating effects of CCK 
between the lean and obese subgroups.
Using the same CCK assay Fried et al found 
in healthy volunteers a CCK increase from 2-6 
(0 • 4) pM to a maximum of 13 (4) pM after the 
ingestion of a mixed meal consisting of 60 g 
boiled chicken breast, 40 g of boiled chicken 
liver, one slice (28 g) of white bread spread 
with 15 g of margarine, 50 g of ice cream, and 
250 ml of lemonade (0-4 M glucose flavoured 
with lemon concentrate).24
This study differs from various other studies 
in several respects. Firstly, a solid meal 
contained almost exclusively carbohydrate 
without recorded CCK stimulation was 
ingested; secondly, infusion of CCK resulted 
in physiological plasma CCK concentrations, 
and thirdly, CCK 33 in contrast with CCK 8 
was infused. In the studies on humans by 
Pi-Sunyer,3 Kissileff,4 Stacher,10 and Shaw11 
where CCK 8 induced feeding depression, 
CCK plasma concentrations were not 
determined and it is probable that supra- 
physiological, pharmacological plasma con­
centrations were achieved. Pi-Sunyer and 
Kissileff infused 4 ng/kg/min of CCK 8, 
which is equivalent to about 3-6 pmol/kg/min
of CCK 8.25
CCK infusion induced a selective reduction
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of preference for fatty foods. This has also 
been shown for endogenous CCK26 and it is 
possible that the suppression of a fatty meal by 
CCK would be stronger than the suppression 
of the carbohydrate meal in our experiment.
We are* however* still a long way from using 
CCK therapeutically as a treatment option for 
obesity. Unfortunately* CCK has to be given 
parenterally and has a very short half life in the 
circulation* making longterm administration 
difficult. Thus oral or nasal preparations with 
prolonged action have to be developed or a 
diet* which powerfully induces endogenous 
CCK release with a minimum of caloric load* 
has to be constituted. Another important 
problem is the lack of studies that show 
weight reduction during longterm administra­
tion.8 913 The meal frequency in rats is 
increased to compensate for the reduction in 
meal size5 7 and tolerance for CCK with 
repeated or continuous infusion supervenes in 
rats.6 27 It may be possible that CCK has to be 
combined with other satiation signals to induce 
weight reduction.
In conclusion* this study has shown that 
infusion of CCK 33 leading to plasma concen­
trations comparable with those after a meal 
decreases food intake in humans and that 
this effect is not different for lean and obese 
subjects.
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